T1	PROC 1 19	Ensayo randomizado
#1	AnnotatorNotes T1	C0206034; Clinical Trials, Randomized; Research Activity
T2	DISO 139 165	tumores de cabeza y cuello
#2	AnnotatorNotes T2	C0018671; Head and Neck Neoplasms; Neoplastic Process
T3	ANAT 159 165	cuello
#3	AnnotatorNotes T3	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T4	DISO 199 225	tumores de cabeza y cuello
#4	AnnotatorNotes T4	C0018671; Head and Neck Neoplasms; Neoplastic Process
T5	ANAT 219 225	cuello
#5	AnnotatorNotes T5	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T6	PROC 238 255	cirugía resectiva
T7	DISO 266 278	desnutrición
#6	AnnotatorNotes T7	C0162429; Malnutrition; Disease or Syndrome
T8	DISO 308 322	complicaciones
T9	PROC 391 422	suplementación oral ambulatoria
T10	PROC 440 478	cirugía por tumores de cabeza y cuello
#7	AnnotatorNotes T10	C4763898; Head and Neck Cancer Surgery; Therapeutic or Preventive Procedure
T11	ANAT 472 478	cuello
#8	AnnotatorNotes T11	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T12	DISO 683 709	tumores de cabeza y cuello
#9	AnnotatorNotes T12	C0018671; Head and Neck Neoplasms; Neoplastic Process
T13	ANAT 703 709	cuello
#10	AnnotatorNotes T13	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T14	ANAT 1184 1189	grasa
#11	AnnotatorNotes T14	C0001527; Adipose tissue; Tissue
T15	DISO 1238 1280	complicaciones infecciosas postoperatorias
T16	CHEM 1517 1542	fórmula enriquecida en w3
T17	DISO 1406 1444	complicaciones de la herida quirúrgica
T18	PROC 1434 1444	quirúrgica
#12	AnnotatorNotes T18	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T19	DISO 1456 1475	efectos secundarios
#13	AnnotatorNotes T19	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T20	ANAT 1558 1563	grasa
#14	AnnotatorNotes T20	C0001527; Adipose tissue; Tissue
T21	PROC 1570 1587	proteínas séricas
#15	AnnotatorNotes T21	C4736732; proteins in serum or plasma; Laboratory Procedure
T22	DISO 1634 1658	tumor de cabeza y cuello
#16	AnnotatorNotes T22	C0018671; Head and Neck Neoplasms; Neoplastic Process
T23	ANAT 1652 1658	cuello
#17	AnnotatorNotes T23	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T24	ANAT 150 156	cabeza
#18	AnnotatorNotes T24	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T25	ANAT 210 216	cabeza
#19	AnnotatorNotes T25	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T26	DISO 452 478	tumores de cabeza y cuello
#20	AnnotatorNotes T26	C0018671; Head and Neck Neoplasms; Neoplastic Process
T27	ANAT 463 469	cabeza
#21	AnnotatorNotes T27	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T28	PROC 622 637	Se randomizaron
#22	AnnotatorNotes T28	C0034656; Randomization; Research Activity
T29	ANAT 694 700	cabeza
#23	AnnotatorNotes T29	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T30	PROC 948 956	albúmina
#24	AnnotatorNotes T30	C0201838; Albumin measurement; Laboratory Procedure
T31	PROC 958 969	prealbúmina
#25	AnnotatorNotes T31	C0337441; Prealbumin measurement; Laboratory Procedure | C1273508; Serum prealbumin level; Laboratory Procedure
T32	PROC 972 984	transferrina
#26	AnnotatorNotes T32	C0202105; Transferrin measurement; Laboratory Procedure
T33	CHEM 1570 1579	proteínas
#27	AnnotatorNotes T33	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T34	ANAT 1580 1587	séricas
#28	AnnotatorNotes T34	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T35	ANAT 1643 1649	cabeza
#29	AnnotatorNotes T35	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T36	CHEM 37 69	fórmula enriquecida en ácidos w3
T37	CHEM 77 108	fórmula enriquecida en arginina
T38	CHEM 491 521	fórmula enriquecida en omega 3
T39	CHEM 535 566	fórmula enriquecida en arginina
T40	CHEM 747 772	fórmula enriquecida en w3
T41	CHEM 780 782	w6
#30	AnnotatorNotes T41	C0133860; fatty acids, omega-6; Organic Chemical · Biologically Active Substance
T42	CHEM 783 785	w3
#31	AnnotatorNotes T42	C0015689; omega-3 fatty acids; Organic Chemical · Biologically Active Substance
T43	CHEM 836 867	fórmula enriquecida en arginina
T44	CHEM 893 895	w6
#32	AnnotatorNotes T44	C0133860; fatty acids, omega-6; Organic Chemical · Biologically Active Substance
T45	CHEM 896 898	w3
#33	AnnotatorNotes T45	C0015689; omega-3 fatty acids; Organic Chemical · Biologically Active Substance
T46	LIVB 112 134	pacientes ambulatorios
#34	AnnotatorNotes T46	C0029921; Outpatients; Patient or Disabled Group
T47	LIVB 185 194	pacientes
#35	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T49	Route 406 410	oral
#36	AnnotatorNotes T49	C1527415; Oral Route of Drug administration; Functional Concept
T50	LIVB 426 435	pacientes
#37	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T52	LIVB 653 662	pacientes
#38	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Date 663 678	postquirúrgicos
#39	AnnotatorNotes T53	C0032790; Postoperative Period; Temporal Concept
T54	Dose 869 879	3,7 g/bote
T56	Date 1265 1280	postoperatorias
#40	AnnotatorNotes T56	C0032790; Postoperative Period; Temporal Concept
T59	LIVB 1591 1600	pacientes
#41	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Date 1601 1616	postquirúrgicos
#42	AnnotatorNotes T60	C0032790; Postoperative Period; Temporal Concept
T48	PROC 1078 1082	peso
#43	AnnotatorNotes T48	C2985231; Body Weight Measurement; Diagnostic Procedure
T51	Dose 819 828	dos botes
T55	Dose 730 739	dos botes
T57	Neg_cue 986 989	sin
T58	CONC 990 1001	diferencias
A1	Assertion T58 Negated
R1	Negation Arg1:T57 Arg2:T58	
T61	Neg_cue 1355 1357	No
T62	CONC 1372 1383	diferencias
A2	Assertion T62 Negated
#44	AnnotatorNotes T62	C1705241; Delta (difference); Quantitative Concept
R2	Negation Arg1:T61 Arg2:T73	
R3	Location_of Arg1:T5 Arg2:T4	
R4	Location_of Arg1:T25 Arg2:T4	
R5	Experiences Arg1:T47 Arg2:T4	
R6	Experiences Arg1:T46 Arg2:T37	
R7	Experiences Arg1:T46 Arg2:T36	
R8	Location_of Arg1:T24 Arg2:T2	
R9	Location_of Arg1:T3 Arg2:T2	
R10	Experiences Arg1:T46 Arg2:T2	
R14	Experiences Arg1:T47 Arg2:T6	
#45	AnnotatorNotes T6	C0728940; Excision; Therapeutic or Preventive Procedure
R15	Overlap Arg1:T4 Arg2:T7	
R16	Experiences Arg1:T47 Arg2:T7	
R17	Overlap Arg1:T4 Arg2:T8	
R18	Experiences Arg1:T47 Arg2:T8	
R19	Has_Route_or_Mode Arg1:T38 Arg2:T49	
R20	Has_Route_or_Mode Arg1:T39 Arg2:T49	
T63	CONC 577 611	variables clínicas y/o bioquímicas
T64	Spec_cue 385 387	si
T65	Observation 568 576	mejoraba
A3	Assertion T65 Speculated
R21	Speculation Arg1:T64 Arg2:T65	
#46	AnnotatorNotes T65	C0184511; Improved; Finding
R22	Experiences Arg1:T50 Arg2:T9	
R23	Experiences Arg1:T50 Arg2:T10	
R24	Location_of Arg1:T27 Arg2:T26	
R25	Location_of Arg1:T11 Arg2:T26	
R26	Experiences Arg1:T50 Arg2:T26	
R27	Location_of Arg1:T27 Arg2:T10	
R28	Location_of Arg1:T11 Arg2:T10	
R30	Used_for Arg1:T38 Arg2:T9	
R31	Used_for Arg1:T39 Arg2:T9	
R32	Before Arg1:T38 Arg2:T65	
R33	Before Arg1:T39 Arg2:T65	
R34	Experiences Arg1:T50 Arg2:T65	
R35	Location_of Arg1:T29 Arg2:T12	
R36	Location_of Arg1:T13 Arg2:T12	
R37	Experiences Arg1:T52 Arg2:T12	
R38	Overlap Arg1:T52 Arg2:T53	
R39	Has_Dose_or_Strength Arg1:T40 Arg2:T55	
R40	Has_Dose_or_Strength Arg1:T43 Arg2:T51	
R41	Has_Dose_or_Strength Arg1:T43 Arg2:T54	
R42	Combined_with Arg1:T41 Arg2:T42	
R43	Combined_with Arg1:T44 Arg2:T45	
T67	CONC 1179 1189	masa grasa
#48	AnnotatorNotes T67	C4764117; Fat Mass; Quantitative Concept
T68	Observation 1148 1158;1173 1189	incremento de la masa grasa
R44	Overlap Arg1:T15 Arg2:T56	
R45	Before Arg1:T18 Arg2:T17	
T70	CONC 1553 1563	masa grasa
#50	AnnotatorNotes T70	C4764117; Fat Mass; Quantitative Concept
R47	Location_of Arg1:T34 Arg2:T21	
R48	Overlap Arg1:T59 Arg2:T60	
R49	Experiences Arg1:T59 Arg2:T21	
R51	Experiences Arg1:T59 Arg2:T16	
R53	Experiences Arg1:T59 Arg2:T22	
R54	Location_of Arg1:T23 Arg2:T22	
R55	Location_of Arg1:T35 Arg2:T22	
T71	Quantifier_or_Qualifier 1617 1629	ambulatorios
#51	AnnotatorNotes T71	C0439841; Ambulatory - qualifier value; Functional Concept 
R46	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T71	
R58	Overlap Arg1:T16 Arg2:T60	
R59	Overlap Arg1:T21 Arg2:T60	
T72	Quantifier_or_Qualifier 1002 1016	significativas
A4	Assertion T72 Negated
#52	AnnotatorNotes T72	C0750502; Significant; Idea or Concept
R61	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T72	
#53	AnnotatorNotes T58	C1705241; Delta (difference); Quantitative Concept (?)
T73	Quantifier_or_Qualifier 1384 1398	significativas
A5	Assertion T73 Negated
#54	AnnotatorNotes T73	C0750502; Significant; Idea or Concept
R62	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T73	
R63	Negation Arg1:T61 Arg2:T62	
#47	AnnotatorNotes T8	C0009566; Complication; Pathologic Function
T66	Quantifier_or_Qualifier 323 335	ambulatorias
#49	AnnotatorNotes T66	C0439841; Ambulatory - qualifier value; Functional Concept
R11	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T66	
A6	Experiencer T59 Patient
A7	Experiencer T46 Patient
A8	Experiencer T47 Patient
A9	Experiencer T50 Patient
A10	Experiencer T52 Patient
